Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.36 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | RBBP9 | O75884 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2592758 | 0.86 | TYR (0.63) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL20444266 | 0.86 | ALDH1A1 (0.34) | TYRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL13780428 | 0.85 | TYR (0.62) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL13780438 | 0.82 | TYR (0.64) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL13780447 | 0.81 | TYR (0.68) | TYRMEN1KMT2AMAPTHKDC1 | |
| Benzoquinone SCHEMBL16556227 | 0.79 | TYR (0.55) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL20176388 | 0.75 | TYR (0.50) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL20437841 | 0.73 | TYR (0.47) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL13780464 | 0.71 | TYR (0.50) | TYRMEN1KMT2AMAPTHKDC1 | |
| SCHEMBL13780445 | 0.71 | TYR (0.50) | TYRMEN1KMT2AMAPTHKDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10781428-B2 | Laccase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2020-09-22 | — | — | US | disclosed |
| US-10577594-B2 | Polypeptides having arabinofuranosidase activity and polynucleotides encoding same | NOVOZYMES, INC. (US) | 2020-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10577594-B2 | Polypeptides having arabinofuranosidase activity and polynucleotides encoding same | ENGASE, RNGTT, MANBA | TYR 3262/4885MEN1 4191/4885KMT2A 4135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.